Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:
Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N.

Journal:
Int Neurourol J

Publication Year: 2021

DOI:
10.5213/inj.2142084.042

PMCID:
PMC8255826

PMID:
34218637

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int Neurourol J

Abbreviation: Int Neurourol J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adreno-Muscarinic Synergy of Contractile Responses From Human Hyperplastic Prostate.
Blake-James BT; Chakrabarty B; Fry CH. (2024) - Transparency Score: 3/6
Application of the Sleep C.A.L.M. Tool for Assessing Nocturia in a Large Nationally Representative …
Boroda JU; De Leon B; Khosla L and 5 more (2024) - Transparency Score: 3/6
Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonis…
Kwon J; Kim DY; Cho KJ and 8 more (2024) - Transparency Score: 3/6
The Ketone Bridge Between the Heart and the Bladder: How Fast Should We Go?
Faria-Costa G; Oliveira J; Vilas-Boas I and 6 more (2024) - Transparency Score: 2/6
Artificial Intelligence-Based Patient Monitoring System for Medical Support.
Kim ES; Eun SJ; Kim KH. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest: T. Ueda reports personal fees from Kyorin, Seikagaku and Japan Tobacco. P.M. Hanno has reports personal fees from Seikagaku, Ironwood, Imbrium, and HTL Biotech. N. Yoshimura reports personal fees from Kyorin and Astellas. R. Saito and J.M. Meijlink report no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025